Covered recipient · General Payments record
NASTASSIA DE SOUZA
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$2,357.10
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $404.39 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $120.57 | 4 |
| Novo Nordisk AS | $115.11 | 5 |
| Amgen Inc. | $47.38 | 2 |
| DEXCOM, INC. | $25.78 | 1 |
| Insulet Corporation | $24.40 | 1 |
| Radius Health, Inc. | $24.21 | 1 |
| Xeris Pharmaceuticals, Inc. | $24.05 | 1 |
| Tandem Diabetes Care, Inc. | $22.89 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $18.08 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115559466 | CMS |
| Amgen Inc. | $29.30 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115559474 | CMS |
| Dexcom, Inc. | $25.78 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153324817 | CMS |
| Insulet Corporation | $24.40 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116809219 | CMS |
| Medtronic, Inc. | $55.99 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119535007 | CMS |
| Medtronic, Inc. | $17.89 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119535009 | CMS |
| Medtronic, Inc. | $29.37 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119535011 | CMS |
| Medtronic, Inc. | $17.32 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119535013 | CMS |
| Novo Nordisk Inc | $23.78 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096580549 | CMS |
| Novo Nordisk Inc | $24.71 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096573928 | CMS |
| Novo Nordisk Inc | $14.17 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097416005 | CMS |
| Novo Nordisk Inc | $19.04 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096593464 | CMS |
| Novo Nordisk Inc | $33.41 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097439300 | CMS |
| Radius Health, Inc. | $24.21 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089978996 | CMS |
| Tandem Diabetes Care, Inc. | $22.89 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138752481 | CMS |
| Xeris Pharmaceuticals, Inc. | $24.05 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144607363 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.